Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2020 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot

  • Authors:
    • Yanjie Zhu
    • Ming Ye
    • Hongfei Xu
    • Ruoyi Gu
    • Xiaojing Ma
    • Mingwu Chen
    • Xiaodi Li
    • Wei Sheng
    • Guoying Huang
  • View Affiliations / Copyright

    Affiliations: Institute of Paediatrics, Children's Hospital of Fudan University, Shanghai 201102, P.R. China, Cardiovascular Centre, Children's Hospital of Fudan University, Shanghai 201102, P.R. China, Department of Forensic Medicine, Soochow University, Suzhou, Jiangsu 215006, P.R. China, Division of Life Sciences and Medicine, The First Affiliated Hospital of The University of Science and Technology of China, Hefei, Anhui 230036, P.R. China
    Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4412-4422
    |
    Published online on: September 24, 2020
       https://doi.org/10.3892/mmr.2020.11535
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Although a lower methylation level of whole genome has been demonstrated in TOF patients, little is known regarding the DNA methylation changes in specific gene and its associations with TOF development. NOTCH4 is a mediator of the Notch signalling pathway that plays an important role in normal cardiac development. However, the role of epigenetic regulation of the NOTCH4 gene in the pathogenesis of TOF remains unclear. Considering the NOTCH4 low mutation frequency and reduced expression in the TOF patients, we hypothesized that abnormal DNA methylation change of NOTCH4 gene may influence its expression and responsible for TOF development. In this study, we measured the promoter methylation status of NOTCH4 and was measured and its regulation mechanism was explored, which may be related to TOF disease. Additionally, the promoter methylation statuses of NOTCH4 was measured in order to further understand epigenetic mechanisms that may serve a role in the development of TOF. Immunohistochemical analysis was used to examine NOTCH4 expression in right ventricular outflow tract myocardial tissues in patients with TOF. Compared with healthy controls, patients with TOF displayed significantly reduced in NOTCH4 expression (P=0.0055). Moreover, bisulphite sequencing suggested that the methylation levels of CpG site 2 in the NOTCH4 promoter was significantly higher in the patients than in the controls (P=0.0459). NOTCH4 expression was negatively associated with CpG site 2 methylation levels (r=‑0.51; P=0.01). ETS1 transcription factor can serve as transcriptional activators by binding to specific DNA sequences of target genes, such as DLL4 and NOTCH4, which serves an important role in normal heart development. Dual‑luciferase reporter and electrophoretic mobility shift assays indicated that the ETS1 transcription factor could bind to the NOTCH4 promoter region. However, binding of ETS1 to the NOTCH4 promoter was abrogated by methylation at the putative ETS1 binding sites. These findings suggested that decreased NOTCH4 expression in patients with TOF may be associated with hypermethylation of CpG site 2 in the NOTCH4 promoter region, due to impaired binding of ETS1.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ and Roos-Hesselink JW: Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol. 58:2241–2247. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Zhao QM, Ma XJ, Ge XL, Liu F, Yan WL, Wu L, Ye M, Liang XC, Zhang J, Gao Y, et al: Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: A prospective study. Lancet. 384:747–754. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Bedard E, Mccarthy KP, Dimopoulos K, Giannakoulas G, Gatzoulis MA and Ho SY: Structural abnormalities of the pulmonary trunk in tetralogy of Fallot and potential clinical implications: A morphological study. J Am Coll Cardiol. 54:1883–1890. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Ho S, Mccarthy KP, Josen M and Rigby ML: Anatomic- echocardiographic correlates: An introduction to normal and congenitally malformed hearts. Heart. 86 (Suppl 2):II3–II11. 2001.PubMed/NCBI

5 

Kathiriya IS, Nora EP and Bruneau BG: Investigating the transcriptional control of cardiovascular development. Circ Res. 116:700–714. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Kaynak B, von Heydebreck A, Mebus S, Seelow D, Hennig S, Vogel J, Sperling HP, Pregla R, Alexi-Meskishvili V, Hetzer R, et al: Genome-wide array analysis of normal and malformed human hearts. Circulation. 107:2467–2474. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Nemer M: Genetic insights into normal and abnormal heart development. Cardiovasc Pathol. 17:48–54. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Simeone RM, Tinker SC, Gilboa SM, Agopian AJ, Oster ME, Devine OJ and Honein MA; National Birth Defects Prevention Study, : Proportion of selected congenital heart defects attributable to recognized risk factors. Ann Epidemiol. 26:838–845. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL, et al: Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American heart association congenital cardiac defects committee, council on cardiovascular disease in the young: Endorsed by the American academy of pediatrics. Circulation. 115:3015–3038. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: Cell fate control and signal integration in developmen. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Luxán G, D'amato G, Macgrogan D and de la Pompa JL: Endocardial Notch signaling in cardiac development and disease. Circ Res. 118:e1–e18. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Mccright B, Lozier J and Gridley T: A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development. 129:1075–1082. 2002.PubMed/NCBI

13 

Digilio MC, Luca AD, Lepri F, Guida V, Ferese R, Dentici ML, Angioni A, Marino B and Dallapiccola B: JAG1 mutation in a patient with deletion 22q11.2 syndrome and tetralogy of Fallot. Am J Med Genet A 161A. 3133–3136. 2013. View Article : Google Scholar

14 

Garg V: Notch signaling in aortic valve development and disease. Nakanishi T, Markwald RR, Baldwin HS, Keller BB, Srivastava D and Yamagishi H: Etiology and morphogenesis of congenital heart disease: From gene function and cellular interaction to morphology [internet]. Tokyo: Springer; 2016, Chapter 53. Jun 25. 2016, View Article : Google Scholar

15 

Meester J, Verstraeten A, Alaerts M, Schepers D, Van Laer L and Loeys BL: Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. Clin Genet. 95:85–94. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, et al: Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14:1343–1352. 2000.PubMed/NCBI

17 

Leong KG, Hu X, Li L, Noseda M, Larrivée B, Hull C, Hood L, Wong F and Karsan A: Activated Notch4 inhibits angiogenesis: Role of beta 1-integrin activation. Mol Cell Biol. 22:2830–2841. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Uyttendaele H, Ho J, Rossant J and Kitajewski J: Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA. 98:5643–5648. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Noseda M, Mclean G, Niessen K, Chang L, Pollet I, Montpetit R, Shahidi R, Dorovini-Zis K, Li L, Beckstead B, et al: Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res. 94:910–917. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Page DJ, Miossec MJ, Williams SG, Monaghan RM, Fotiou E, Cordell H, Sutcliffe L, Topf A, Bourgey M, Bourque G, et al: Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of Fallot. Circ Res. 124:553–563. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Shames DS, Minna JD and Gazdar AF: DNA methylation in health, disease, and cancer. Curr Mol Med. 7:85–102. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Boyes J and Bird A: DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell. 64:1123–1134. 1991. View Article : Google Scholar : PubMed/NCBI

23 

Sheng W, Chen L, Wang H, Ma X, Ma D and Huang G: CpG island shore methylation of ZFPM2 is identified in tetralogy of Fallot samples. Pediatr Res. 80:151–158. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Sheng W, Qian Y, Wang H, Ma X, Zhang P, Diao L, An Q, Chen L, Ma D and Huang G: DNA methylation status of NKX2-5, GATA4 and HAND1 in patients with tetralogy of Fallot. BMC Med Genomics. 6:462013. View Article : Google Scholar : PubMed/NCBI

25 

Gong J, Sheng W, Ma D, Huang G and Liu F: DNA methylation status of TBX20 in patients with tetralogy of Fallot. BMC Med Genomics. 12:752019. View Article : Google Scholar : PubMed/NCBI

26 

Emeny RT, Baumert J, Zannas AS, Kunze S, Wahl S, Iurato S, Arloth J, Erhardt A, Balsevich G, Schmidt MV, et al: Anxiety associated increased CpG methylation in the promoter of Asb1: A translational approach evidenced by epidemiological and clinical studies and a murine model. Neuropsychopharmacology. 43:342–353. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Bind MA, Coull BA, Peters A, Baccarelli AA, Tarantini L, Cantone L and Schwartz JD, Vokonas PS, Koutrakis P and Schwartz JD: Beyond the mean: Quantile regression to explore the association of air pollution with gene-specific methylation in the normative aging study. Environ Health Perspect. 123:759–765. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Somineni HK, Zhang X, Biagini MJ, Kovacic MB, Ulm A, Jurcak N, Ryan PH, Hershey GKK and Ji H: Ten-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution. J Allergy Clin Immunol. 137:797–805.e5. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Plusquin M, Guida F, Polidoro S, Vermeulen R, Raaschou-Nielsen O, Campanella G, Hoek G, Kyrtopoulos SA, Georgiadis P, Naccarati A, et al: DNA methylation and exposure to ambient air pollution in two prospective cohorts. Environ Int. 108:127–136. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Wythe JD, Dang LT, Devine WP, Boudreau E, Artap ST, He D, Schachterle W, Stainier DYR, Oettgen P, Black BL, et al: ETS factors regulate Vegf-dependent arterial specification. Dev Cell. 26:45–58. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Oikawa T and Yamada T: Molecular biology of the Ets family of transcription factors. Gene. 303:11–34. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS and Seth A: The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA. 90:7588–7592. 1993. View Article : Google Scholar : PubMed/NCBI

33 

Ye M, Coldren C, Liang X, Mattina T, Goldmuntz E, Benson DW, Ivy D, Perryman MB, Garrett-Sinha LA and Grossfeld P: Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet. 19:648–656. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Gao Z, Kim GH, Mackinnon AC, Flagg AE, Bassett B, Earley JU and Svensson EC: Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development. 137:1543–1551. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Ramirez K, Chandler KJ, Spaulding C, Zandi S, Sigvardsson M, Graves BJ and Kee BL: Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity. 36:921–932. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Li RZ, Pei HP, Watson DK and Papas TS: EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene. 19:745–753. 2000. View Article : Google Scholar : PubMed/NCBI

37 

Pham VN, Lawson ND, Mugford JW, Dye L, Castranova D, Lo B and Weinstein BM: Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol. 303:772–783. 2007. View Article : Google Scholar : PubMed/NCBI

38 

TFSEARCH, . http://www.cbrc.jp/research/db/TFSEARCH.htmlJune 13–2020

39 

JASPAR database, . http://jaspar.binf.ku.dk/cgi-bin/jaspar_db.pl?rm=browse&db=core&tax_group=vertebratesJune 13–2020

40 

Iso T, Hamamori Y and Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol. 23:543–553. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML and Weinmaster G: Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 108:161–164. 2001. View Article : Google Scholar : PubMed/NCBI

42 

Wu B, Zhang Z, Lui W, Chen X, Wang Y, Chamberlain AA, Moreno-Rodriguez RA, Markwald RR, O'Rourke BP, Sharp DJ, et al: Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell. 151:1083–1096. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Wu B, Wang Y, Lui W, Langworthy M, Tompkins KL, Hatzopoulos AK, Baldwin HS and Zhou B: Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ Res. 109:183–192. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Borgel J, Guibert S, Li Y, Chiba H, Schübeler D, Sasaki H, Forné T and Weber M: Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet. 42:1093–1100. 2010. View Article : Google Scholar : PubMed/NCBI

45 

Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science. 293:1068–1070. 2001. View Article : Google Scholar : PubMed/NCBI

46 

Chamberlain AA, Lin M, Lister RL, Maslov AA, Wang Y, Suzuki M, Wu B, Greally JM, Zheng D and Zhou B: DNA methylation is developmentally regulated for genes essential for cardiogenesis. J Am Heart Assoc. 3:e9762014. View Article : Google Scholar

47 

Feinberg AP: The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 378:1323–1334. 2018. View Article : Google Scholar : PubMed/NCBI

48 

Sheng W, Wang H, Ma X, Qian Y, Zhang P, Wu Y, Zheng F, Chen L, Huang G and Ma D: LINE-1 methylation status and its association with tetralogy of fallot in infants. BMC Med Genomics. 5:202012. View Article : Google Scholar : PubMed/NCBI

49 

Tsuboi K, Nagatomo T, Gohno T, Higuchi T, Sasaki S, Fujiki N, Kurosumi M, Takei H, Yamaguchi Y, Niwa T and Hayashi SI: Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance. J Steroid Biochem Mol Biol. 171:209–217. 2017. View Article : Google Scholar : PubMed/NCBI

50 

Fürst RW, Kliem H, Meyer HH and Ulbrich SE: A differentially methylated single CpG-site is correlated with estrogen receptor alpha transcription. J Steroid Biochem Mol Biol. 130:96–104. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Bartels SJ, Spruijt CG, Brinkman AB, Jansen PW, Vermeulen M and Stunnenberg HG: A SILAC-based screen for Methyl-CpG binding proteins identifies RBP-J as a DNA methylation and sequence-specific binding protein. PLoS One. 6:e258842011. View Article : Google Scholar : PubMed/NCBI

52 

Mann IK, Chatterjee R, Zhao J, He X, Weirauch MT, Hughes TR and Vinson C: CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res. 23:988–997. 2013. View Article : Google Scholar : PubMed/NCBI

53 

Irizarry RA, Ladd-Acosta C, Wen B, Wu ZJ, Montano C, Onyango P, Cui HM, Gabo K, Rongione M, Webster M, et al: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 41:178–186. 2009. View Article : Google Scholar : PubMed/NCBI

54 

Portela A and Esteller M: Epigenetic modifications and human disease. Nat Biotechnol. 28:1057–1068. 2010. View Article : Google Scholar : PubMed/NCBI

55 

Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, et al: Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol. 30:2483–2491. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Ceccarelli V, Racanicchi S, Martelli MP, Nocentini G, Fettucciari K, Riccardi C, Marconi P, Nardo PD, Grignani F, Binaglia L and Vecchini A: Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells. J Biol Chem. 286:27092–27102. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhu Y, Ye M, Xu H, Gu R, Ma X, Chen M, Li X, Sheng W and Huang G: Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot. Mol Med Rep 22: 4412-4422, 2020.
APA
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M. ... Huang, G. (2020). Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot. Molecular Medicine Reports, 22, 4412-4422. https://doi.org/10.3892/mmr.2020.11535
MLA
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M., Li, X., Sheng, W., Huang, G."Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot". Molecular Medicine Reports 22.5 (2020): 4412-4422.
Chicago
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M., Li, X., Sheng, W., Huang, G."Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot". Molecular Medicine Reports 22, no. 5 (2020): 4412-4422. https://doi.org/10.3892/mmr.2020.11535
Copy and paste a formatted citation
x
Spandidos Publications style
Zhu Y, Ye M, Xu H, Gu R, Ma X, Chen M, Li X, Sheng W and Huang G: Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot. Mol Med Rep 22: 4412-4422, 2020.
APA
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M. ... Huang, G. (2020). Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot. Molecular Medicine Reports, 22, 4412-4422. https://doi.org/10.3892/mmr.2020.11535
MLA
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M., Li, X., Sheng, W., Huang, G."Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot". Molecular Medicine Reports 22.5 (2020): 4412-4422.
Chicago
Zhu, Y., Ye, M., Xu, H., Gu, R., Ma, X., Chen, M., Li, X., Sheng, W., Huang, G."Methylation status of CpG sites in the NOTCH4 promoter region regulates NOTCH4 expression in patients with tetralogy of Fallot". Molecular Medicine Reports 22, no. 5 (2020): 4412-4422. https://doi.org/10.3892/mmr.2020.11535
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team